Thus, despite being developed in melanoma cells, the upregulated genes in our YAP/TAZ signature are highly enriched in other cancer cell types with YAP/TAZ-TEAD activation, and the enrichment of this geneset is predictive of cancer cell sensitivity to the loss of YAP/TAZ or TEADs. This evidence concerns the gene YAP1 and cancer.